The purpose of this study is to identify novel urine protein biomarkers of bladder cancer using a Luminex based screening platform.
The current study examines urine samples from 66 subjects, comprised of 31 Urology clinic controls and 35 bladder cancer patients, using a Luminex based screening platform.